Mukka Proteins Files SEBI Compliance Certificate for Q3 FY26
Mukka Proteins Limited submitted a compliance certificate for the quarter ended December 31, 2025. The RTA confirmed no demat requests were processed as no shares are held in physical form.
This is a standard regulatory filing and is unlikely to have any material impact on the company's operations or stock performance.
The announcement is a routine compliance filing and does not contain any new financial information or significant business developments that would impact the company's stock price.
Mukka Proteins Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent, Cameo Corporate Services Limited, confirmed that no demat requests were received for processing during this period, as the company's shares are not held in physical form.
This filing is a routine compliance report to the National Stock Exchange of India Limited and BSE Limited. The certificate from Cameo Corporate Services Limited, dated January 9, 2026, reiterates that no shares were processed for dematerialization as there were no physical shares outstanding for the company during the specified quarter.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.